Full Press Release Details
2.7, 3.10.3, 3.10.4, 3.10.5
New Issue Announcement,
Application for Quotation of Additional
Securities and Agreement
or documents not available now must be given to ASX as soon as available.
and documents given to ASX become ASX's property and may be made public.
01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
| Name of Entity |
| Alterity Therapeutics Limited (ASX: ATH) |
| ABN |
| 37 080 699 065 |
entity) give ASX the following information.
must complete the relevant sections (attach sheets if there is not enough space).
| 1 | +Class of +securities issued or to be issued | Ordinary Shares (ATH) |
| 2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 7,962,060 |
| 3 | Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | Fully paid ordinary shares (ATH) |
| 4 | Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | Yes |
| 5 | Issue price or consideration | USD 191,912 |
| 6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | To fund the Company's current clinical development, research programs and working capital. This is an on-going placement - more tranches will be allotted in the future. |
| 6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B , and comply with section 6i | Yes |
| 6b | The date the security holder resolution under rule 7.1A was passed | 16 November 2018 |
| 6c | Number of +securities issued without security holder approval under rule 7.1 | 7,962,060 |
| 6d | Number of +securities issued with security holder approval under rule 7.1A | Nil |
| 6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | Nil |
| 6f | Number of +securities issued under an exception in rule 7.2 | Nil |
| 6g | If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. | N/A |
| 6h | If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | N/A |
| 6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | Refer to the attached Annexure 1 |
| Number | + Class | ||||
| 8 | Number and +class of all +securities quoted on ASX ( including the +securities in section 2 if applicable) | 868,799,492 | Fully Paid Ordinary Shares (ATH) | ||
| 9 | Number and + class of all + securities not quoted on ASX ( including the + securities in section 2 if applicable) |
| Class of Securities | Issued | ||||||||||||||
| ASX Code | Number | Security Type | Exercise Price | Expiry Date | under an ESOP | ||||||||||
| PBTAH | 2,000,000 | Unlisted Options | AUD$0.26 | 18 Feb 2020 | 2004 ASX Plan | ||||||||||
| PBTAR | 1,400,000 | Unlisted Options | AUD$0.27 | 25 May 2020 | 2004 ASX Plan | ||||||||||
| PBTAS | 7,350,000 | Unlisted Options | AUD$0.07 | 6 Jun 2022 | 2004 ASX Plan | ||||||||||
| PBTAAA | 13,850,000 | Unlisted Options | AUD$0.11 | 14 Dec 2022 | 2004 ASX Plan | ||||||||||
| PBTAI | 700,000 | Unlisted Options | AUD $0.083 | 31 January 2023 | 2004 ASX Plan | ||||||||||
| NEW CLASS | 586,672,964 | Short-term warrants | AUD $0.045 | 19 December 2019 | No | ||||||||||
| TOTAL | 611,972,964 |
Part 2 - Pro rata issue - n/a
| 11 | Is security holder approval required? | |
| 12 | Is the issue renounceable or non-renounceable? | |
| 13 | Ratio in which the + securities will be offered | |
| 14 | + Class of + securities to which the offer relates | |
| 15 | + Record date to determine entitlements |
| 16 | Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? | |
| 17 | Policy for deciding entitlements in relation to fractions | |
| 18 | Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. | |
| 19 | Closing date for receipt of acceptances or renunciations | |
| 20 | Names of any underwriters | |
| 21 | Amount of any underwriting fee or commission | |
| 22 | Names of any brokers to the issue | |
| 23 | Fee or commission payable to the broker to the issue | |
| 24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders | |
| 25 | If the issue is contingent on security holders' approval, the date of the meeting | |
| 26 | Date entitlement and acceptance form and offer documents will be sent to persons entitled | |
| 27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders | |
| 28 | Date rights trading will begin (if applicable) |
| 29 | Date rights trading will end (if applicable) | |
| 30 | How do security holders sell their entitlements in full through a broker? | |
| 31 | How do security holders sell part of their entitlements through a broker and accept for the balance? |
| 32 | How do security holders dispose of their entitlements (except by sale through a broker)? | |
| 33 | + Issue date |
Part 3 - Quotation of securities
need only complete this section if you are applying for quotation of securities
| 34 | Type of + securities ( tick one ) | |
| (a) | + Securities described in Part 1 | |
| (b) | All other + securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities |
Entities that have ticked box 34(a)
Additional securities forming a new
class of securities - n/a
| 35 | If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders | |
| 36 | If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over | |
| 37 | A copy of any trust deed for the additional +securities |
Entities that have ticked box 34(b)
| 38 | Number of + securities for which + quotation is sought | ||
| 39 | + Class of + securities for which quotation is sought | ||
| 40 | Do the + securities rank equally in all respects from the + issue date with an existing + class of quoted + securities? If the additional + securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment | ||
| 41 | Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another + security, clearly identify that other + security) | ||
| Number | + Class | ||
| 42 | Number and + class of all + securities quoted on ASX ( including the + securities in clause 38) |
may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
| /s/ Phillip Hains | Date: Thursday, 1 st August 2019 | |
| Sign here: | Company Secretary | |
| Print name: | Phillip Hains |
Calculation of placement capacity under
rule 7.1 and rule 7.1A for eligible entities
01/08/12 Amended 04/03/13
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
| Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue | 536,975,050 |
| Add the following: Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2 Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval Number of partly paid +ordinary securities that became fully paid in that 12 month period Note: Include only ordinary securities here - other classes of equity securities cannot be added Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed It may be useful to set out issues of securities on different dates as separate line items | Nil 311,038,282 Nil |
| Subtract the number of fully paid +ordinary securities cancelled during that 12 month period | Nil |
| "A" | 848,013,332 |
| Step 2: Calculate 15% of "A" | |
| "B" | 0.15 [Note: this value cannot be changed] |
| Multiply "A" by 0.15 | 127,202,000 |
| Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used | |
| Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued: Under an exception in rule 7.2 Under rule 7.1A With security holder approval under rule 7.1 or rule 7.4 Note: This applies to equity securities, unless specifically excluded - not just ordinary securities Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed It may be useful to set out issues of securities on different dates as separate line items | 20,786,160 |
| "C" | 20,786,160 |
| Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1 | |
| "A" x 0.15 Note: number must be same as shown in Step 2 | 127,202,000 |
| Subtract "C" Note: number must be same as shown in Step 3 | 20,786,160 |
| Total ["A" x 0.15] - "C" | 106,415,840 [ Note : this is the remaining placement capacity under rule 7.1] |
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement capacity is calculated
Step 2: Calculate 10% of "A"
| "D" | 0.10 Note: this value cannot be changed |
| Multiply "A" by 0.10 | 84,801,333 |
Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used
| Insert number of +equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: This applies to equity securities - not just ordinary securities Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained It may be useful to set out issues of securities on different dates as separate line items | Nil |
| "E" | Nil |
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A
| " A " x 0.10 Note: number must be same as shown in Step 2 | 84,801,333 |
| Subtract "E" Note: number must be same as shown in Step 3 | Nil |
| Total ["A" x 0.10] - "E" | 84,801,333 Note: This is the remaining placement capacity under rule 7.1A |
Under Section 708A(5) of the Corporations Act
notice is given under paragraph (5)(e) of section 708A of the Corporations Act.
| Type: | Shares | |
| Class/Description: | Ordinary Fully Paid | |
| ASX Code: | ATH | |
| Date of Issue: | Wednesday, 31 st July 2019 | |
| Number Issued: | 7,962,060 | |
| Issue Consideration: | USD 191,912 |
Company intends to apply to Australian Stock Exchange Limited for quotation of the above shares.
Accordingly, the Company
gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:
and on behalf of the Company,
| /s/ Phillip Hains | ||
| Phillip Hains Company Secretary Alterity Therapeutics Limited |